Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCalnex Solutio. Regulatory News (CLX)

Share Price Information for Calnex Solutio. (CLX)

Share Price is delayed by 15 minutes
Get Live Data
68.50    0.00 (0.00%)
Bid:
67.00
Ask:
70.00
Spread: 3.00 (4.478%)
Market Cap: £60.33m
CLX Live PriceLast checked at - London Stock Exchange

Intraday Calnex Solutio. Share Chart

AGM Statement

19 Aug 2021 07:00

RNS Number : 0241J
Calnex Solutions PLC
19 August 2021
 

19 August 2021

 

Calnex Solutions plc

("Calnex", the "Company" or the "Group")

 

AGM Statement

Calnex Solutions plc, an established provider of test and measurement solutions for the global telecommunications sector, is pleased to provide an update on trading ahead of its Annual General Meeting taking place at 9am today.

 

Calnex has continued to achieve strong trading and good order levels in the first quarter of FY22, in line with the Board's expectations. Of note in the first few months of the year has been a positive response to the Group's enhancements to its Lab Sync platform, Paragon-Neo, with customers placing encouraging levels of pre-orders ahead of launch later in the year. This new functionality will support testing on the very high speed 400G interface and the new PAM4 interface format. This is a key technology development which is expected to be widely adopted, as organisations upgrade their network infrastructure to cope with the increasing amount of data as a result of the increase in cloud computing and evolution to 5G. Additional recent product developments include the enhancement of our Field Sync platform with, what the Board believes is, the unique ability to test 5G Networks alongside the 3G and 4G support already available, increasing the attractiveness of the platform as telecoms operators look to maintaining their new 5G networks. Whilst cognisant of the uncertainty in the wider industry over the ongoing global semiconductor shortage, the Group has not experienced any negative impact on the ability to manufacture and ship product to date, and the Board continues to monitor the situation closely.

 

The Company was also pleased to receive a Gold standard accreditation from Investors in People, reflecting recognition of Calnex as an organisation with the very best in people management excellence.

 

The strength of trading and positive evolutionary trends affecting the telecoms sector described above provide the Board with continued confidence in Calnex's ability to deliver on its growth strategy and a positive outcome to the year in line with current market expectations.

 

For more information, please contact:

 

Calnex Solutions plc

Via Alma PR

Tommy Cook, Chief Executive Officer

Ashleigh Greenan, Chief Financial Officer

 

 

 

Cenkos Securities plc - NOMAD

+44 (0)131 220 6939

Derrick Lee, Peter Lynch

 

 

 

Alma PR

+ 44(0) 20 3405 0213

Caroline Forde, Harriet Jackson, Joe Pederzolli

 

 

 

Overview of Calnex

 

Calnex designs, produces and markets test instrumentation and solutions for network synchronization and network emulation, enabling its customers to validate the performance of the critical infrastructure associated with telecoms networks. To date, Calnex has secured and delivered orders to over 600 customer sites in 68 countries across the world. Customers include BT, China Mobile, NTT, Ericsson, Nokia, Intel, Qualcomm, IBM and Facebook.

 

Founded in 2006, Calnex is headquartered in Linlithgow, Scotland, with additional locations in Belfast, Northern Ireland and California in the US, supported by sales teams in China and India. Calnex has a global network of partners, providing a worldwide distribution capability. 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMSFWSAAEFSEFA
Date   Source Headline
15th Oct 20219:33 amRNSPDMR Dealing
12th Oct 20217:00 amRNSTrading Update
7th Sep 20217:00 amRNSAward of Options
19th Aug 20215:05 pmRNSResult of AGM
19th Aug 20217:00 amRNSAGM Statement
4th Aug 20214:34 pmRNSHolding(s) in Company
15th Jul 20212:53 pmRNSDirector Dealing
28th Jun 20217:00 amRNSNotice of AGM and Posting of Annual Report
16th Jun 20214:26 pmRNSPDMR Dealing
25th May 20217:00 amRNSFY21 Final Results
17th May 20217:00 amRNSNotice of Results and Investor Presentation
15th Apr 202112:31 pmRNSPDMR Shareholding
1st Apr 20214:05 pmRNSPDMR/PCA Dealing
24th Mar 20214:14 pmRNSPDMR Dealing
16th Feb 20217:00 amRNSTrading Update
1st Feb 20213:53 pmRNSPDMR Dealing
10th Dec 20202:05 pmRNSSecond Price Monitoring Extn
10th Dec 20202:00 pmRNSPrice Monitoring Extension
25th Nov 202011:05 amRNSSecond Price Monitoring Extn
25th Nov 202011:00 amRNSPrice Monitoring Extension
25th Nov 20209:00 amRNSPrice Monitoring Extension
25th Nov 20207:00 amRNSInterim Results
23rd Nov 20202:01 pmRNSPrice Monitoring Extension
23rd Nov 202011:05 amRNSSecond Price Monitoring Extn
23rd Nov 202011:00 amRNSPrice Monitoring Extension
23rd Nov 20209:05 amRNSSecond Price Monitoring Extn
23rd Nov 20209:00 amRNSPrice Monitoring Extension
12th Oct 20206:10 pmRNSHolding(s) in Company
8th Oct 20207:00 amRNSHolding(s) in Company
6th Oct 20207:00 amRNSHolding(s) in Company
6th Oct 20207:00 amRNSHolding(s) in Company
5th Oct 20207:00 amRNSAdmission to AIM and First Day of Dealings
24th Jul 20077:00 amRNSHigh Court Sanction of Scheme
19th Jul 20073:51 pmRNSAIM & IEX Cancellation Update
9th Jul 20077:00 amRNSIEX Notice
3rd Jul 20078:20 amRNSIssue of Equity
2nd Jul 20075:36 pmRNSResult of EGM-Replacement
2nd Jul 20074:45 pmRNSResult of EGM
2nd Jul 200711:04 amRNSFinal Cash Payment from Calyx
28th Jun 200710:00 amRNSAnnual Report and Accounts
25th Jun 200711:37 amRNSAIM & IEX Cancellation
8th Jun 200712:06 pmRNSPosting of Scheme Document
7th Jun 20071:25 pmRNSOffer Update
1st Jun 20077:01 amRNSOffer Update
30th May 20075:41 pmRNSOffer Update
30th May 200711:01 amRNSRule 8.3- Calyx Group PLC
25th May 20077:02 amRNSOffer for Calyx Group plc
3rd May 200711:03 amRNSUpdate on Possible Offer
17th Apr 200710:20 amRNSPreliminary Results
17th Apr 20077:01 amRNSUpdate on Possible Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.